Skip to main content
Log in

Ovarian activity during follicular-phase down regulation in in vitro fertilization is associated with advanced maternal age and a high recurrence rate in subsequent cycles

  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

Previous reports have suggested that the ovarian response to leuprolide acetate is predictive of in vitro fertilization pregnancy rates. This study evaluated the outcome of in vitro fertilization cycles complicated by elevated estradiol levels during leuprolide acetate down regulation and the outcome of subsequent cycles in the same patients.

Methods

Two hundred fifty-two in vitro fertilization cycles were initiated utilizing leuprolide acetate down regulation beginning on cycle day 1.

Results

Seventy-four of these cycles had an elevated estradiol level at the time of the baseline scan (28%). This group of patients had a higher maternal age, a higher cycle cancellation rate (27.5 vs 16.3%), and a high rate of recurrence on subsequent cycles (63%).

Conclusions

The pregnancy rate per retrieval was equivalent in the two groups. This suggests that patients with advanced maternal age or a history of failure to suppress in a previous cycle may benefit from alternate regimens of superovulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Meldrum DR, Wisot A, Hamilton F, Gutlay AL, Huynh D, Kempton W: Timing of initiation and dose schedule of leuprolide influence the time course of ovarian suppression. Fertil Steril 1988;50:400–402

    PubMed  Google Scholar 

  2. Jenkins JM, Davies DW, Anthony F, Wood P, Gadd SG, Watson RH, Masson GM: The detrimental influence of functional ovarian cysts during in-vitro fertilization cycles. Hum Reprod 1992;7:776–780

    PubMed  Google Scholar 

  3. Parinaud J, Cohen K, Oustry P, Perineau M, Monroziè X, Rème J-M: Influence of ovarian cysts on the results of in vitro fertilization. Fertil Steril 1992;58:1174–1177

    PubMed  Google Scholar 

  4. Ibrahim ZHZ, Matson PL, Buck P, Critchlow JD, Newman MC, Home G, Hughes S, Lieberman BA: Use of buserelin in an IVF programme for pituitary-ovarian suppression prior to ovarian stimulation with exogenous gonadotrophins. Hum Reprod 1990;5:258–2624

    PubMed  Google Scholar 

  5. Padilla SL, Bayati J, Garcia JE: Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization. Fertil Steril 1990;53:288–294

    PubMed  Google Scholar 

  6. Padilla SL, Smith RD, Garcia JE: The Lupron screening test: Tailoring the use of leuprolide acetate in ovarian stimulation for in vitro fertilization. Fertil Steril 1991;56:79–83

    PubMed  Google Scholar 

  7. Lasley BL, Wang CF, Yen SSC: The effects of estrogen and progesterone on the functional capacity of the gonadotrophs. J Clin Endocrinol Metab 1975;41:820–826

    PubMed  Google Scholar 

  8. Roth JC, Kelch RP, Kaplan SL, Grumbach MM: FSH and LH response to luteinizing hormone-releasing factor in prepubertal and pubertal children, adult males and patients with hypogonadotropic and hypergonadotropic hypogonadism. J Clin Endocrinol Metab 1972;35:926–930

    PubMed  Google Scholar 

  9. Ben-Rafael Z, Bider D, Menashe Y, Maymon R, Zolti M, Mashiach S: Follicular and luteal cysts after treatment with gonadotropin-releasing hormone analog for in vitro fertilization. Fertil Steril 1990;53:1091–1094

    PubMed  Google Scholar 

  10. Ron-El R, Herman A, Golan A, van der Ven H, Caspi E, Diedrich K: The comparison of early follicular and midluteal administration of long-acting gonadotropin-releasing hormone agonist. Fertil Steril 1990;54:233–237

    PubMed  Google Scholar 

  11. Seifer DB, Thornton KL, DeCherney AH, Lavy G: Early pituitary desensitization and ovarian suppression with leuprolide acetate is associated with in vitro fertilizationembryo transfer success. Fertil Steril 1991;56:500–504

    PubMed  Google Scholar 

  12. Jenkins JM, Anthony FW, Wood P, Rushen D, Masson GM, Thomas E: The development of functional ovarian cysts during pituitary down-regulation. Hum Reprod 1993;8:1623–1627

    PubMed  Google Scholar 

  13. Martinez F, Arri PN, Coroleu V: Case report: Accidental GnRH agonist administration during early pregnancy. Hum Reprod 1988;3:669

    PubMed  Google Scholar 

  14. Hugues JN, Attalah M, Hervé F, Martin-Pont B, Kottler ML, Santarelli J: Effects of short-term GnRH agonist-human menopausal gonadotrophin stimulation in patients pretreated with progestogen. Hum Reprod 1992;7:1079–1084

    PubMed  Google Scholar 

  15. Patton PE, Burry KA, Wolf DP, Kiessling AA, Craemer MJ: The use of oral contraceptives to regulate oocyte retrieval. Fertil Steril 1988;49:716–718

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Session, D.R., Saad, A.H., Salmansohn, D.D. et al. Ovarian activity during follicular-phase down regulation in in vitro fertilization is associated with advanced maternal age and a high recurrence rate in subsequent cycles. J Assist Reprod Genet 12, 301–304 (1995). https://doi.org/10.1007/BF02213708

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02213708

Key words

Navigation